Nirvana Life Sciences Inc. (CSE:NIRV)

Canada flag Canada · Delayed Price · Currency is CAD
0.0700
-0.0050 (-6.67%)
Jan 20, 2026, 9:04 AM EST
-86.00%
Market Cap1.60M
Revenue (ttm)n/a
Net Income (ttm)-375.89K
Shares Out22.92M
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,000
Average Volume5,581
Open0.0700
Previous Close0.0750
Day's Range0.0700 - 0.0700
52-Week Range0.0300 - 0.3500
Beta-0.07
RSI45.68
Earnings DateMar 31, 2026

About Nirvana Life Sciences

Nirvana Life Sciences Inc. engages in the research and development of therapeutic products and medicines to address addiction. It also provides gel caps transition from opioids to non-addictive pain relief therapies. The company is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Bruce Clark
Employees 2
Stock Exchange Canadian Securities Exchange
Ticker Symbol NIRV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.